Risk assessments (EMCDDA)
(35) Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (2022) (34) Report on...
(35) Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (2022) (34) Report on...
(37) Prisons and drugs in Europe: the problem and responses (2012) (36) Pregnancy, childcare and the family: key issues for Europe’s response to drugs...
In issue 8 of the edition of the National Focal Point on Drugs and Drug Addictions NEWS – Bulletin for the new psychoactive substances...
(100) Drugnet Europe – Newsletter of the EMCCDA (October – December 2017) (99) Drugnet Europe – Newsletter of the EMCDDA (July – September 2017)...